MacroGenics, Inc. ( MGNX) - Key Metrics
MGNX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.65 | -$0.22 | $0.68 | $0.68 |
| 2025Q3 | $1.15 | $0.27 | -$0.48 | -$0.48 |
| 2025Q2 | $0.35 | -$0.57 | -$0.74 | -$0.76 |
| 2025Q1 | $0.21 | -$0.65 | -$0.74 | -$0.75 |
MGNX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -1.80 |
| 2025Q3 | ? | 1.58 |
| 2025Q2 | ? | -0.53 |
| 2025Q1 | ? | -0.49 |
MGNX Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -19.72% | ? |
| 2025Q4 | 42.07% | ? |
| 2025Q3 | -28.82% | ? |
| 2025Q2 | -62.44% | ? |
| 2025Q1 | -59.30% | ? |
MGNX
Price: $3.94
52 week price:
Earnings Per Share: -1.11 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 382181
Ebitda: -45.8 millionMarket Capitalization: 248.5 million